Biotechnology Stocks
| # | Son 7 Gün | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1138 |  SRRK Scholar Rock Holding Corporation - Common Stock | 56.07 USD | -0.76% | +7.60% | +15.30% | +86.78% | 6.83 B USD | ||
| 1185 |  COGT Cogent Biosciences, Inc. - Common Stock | 36.28 USD | -1.23% | -4.12% | -9.41% | +131.53% | 6.30 B USD | ||
| 1192 |  BLTE Belite Bio Inc - American Depositary Shares | 159.15 USD | -1.19% | -2.26% | +3.12% | +145.60% | 6.26 B USD | ||
| 1199 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 95.71 USD | -0.62% | -4.45% | -16.88% | +36.48% | 6.21 B USD | ||
| 1206 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 109.70 USD | -1.26% | -4.88% | +5.64% | +351.44% | 6.14 B USD | ||
| 1207 |  TVTX Travere Therapeutics, Inc. - Common Stock | 64.15 USD | -2.37% | +2.53% | +10.70% | +122.98% | 6.05 B USD | ||
| 1210 |  ERAS Erasca, Inc. - Common Stock | 17.17 USD | -2.61% | -6.53% | -11.77% | +986.71% | 6.01 B USD | ||
| 1212 |  LQDA Liquidia Corporation - Common Stock | 68.57 USD | -0.07% | -9.43% | -20.44% | +203.41% | 6.14 B USD | ||
| 1230 |  DFTX Definium Therapeutics, Inc. - Common Shares | 42.45 USD | -5.48% | -3.63% | -2.75% | +180.94% | 5.70 B USD | ||
| 1240 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 60.35 USD | -0.69% | -2.05% | -7.93% | +47.95% | 5.84 B USD | ||
| 1251 |  PTCT PTC Therapeutics, Inc. - Common Stock | 68.20 USD | -2.32% | -4.89% | -12.14% | +34.68% | 5.69 B USD | ||
| 1260 |  CRSP CRISPR Therapeutics AG - Common Shares | 57.20 USD | -3.87% | +7.42% | +20.02% | +5.44% | 5.53 B USD | ||
| 1266 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 281.87 USD | -1.54% | -4.59% | -7.57% | +50.64% | 5.62 B USD | ||
| 1344 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 29.26 USD | -0.81% | +2.49% | +16.07% | +14.03% | 5.04 B USD | ||
| 1372 |  DYN Dyne Therapeutics, Inc. - Common Stock | 25.38 USD | -2.76% | -0.47% | +1.52% | +8.42% | 4.74 B USD | ||
| 1382 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 43.20 USD | -2.22% | -0.32% | +3.85% | +183.65% | 4.69 B USD | ||
| 1418 |  CELC Celcuity Inc. - Common Stock | 91.32 USD | -2.36% | -0.72% | +8.57% | +72.56% | 4.47 B USD | ||
| 1449 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 59.68 USD | -0.23% | +1.96% | +10.97% | +188.87% | 4.37 B USD | ||
| 1468 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 39.27 USD | +1.58% | +77.61% | +112.27% | +323.17% | 4.38 B USD | ||
| 1477 |  RLAY Relay Therapeutics, Inc. - Common Stock | 18.88 USD | -2.88% | -5.93% | +2.22% | +411.65% | 4.14 B USD |
Haberler Biotechnology Stocks
Deutsche Bank, argenx hissesini değerleme nedeniyle Tut’a düşürdü
Monte Rosa Therapeutics hissesi neden düşüyor?
Biomea Fusion hisseleri diyabet çalışması kayıt tamamlanmasıyla yükseldi
Monte Rosa hisseleri faz 2 prostat kanseri çalışması başlarken düştü
H.C. Wainwright, Biomea Fusion hissesi için hedef fiyatı korudu
Crinetics Pharmaceuticals hissesi 84,8 dolarda zirve yaptı
FDA, Capricor’un deramiocel incelemesini 22 Kasım’a uzattı
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
 ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
 OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |